Arizona Cancer Center Biospecimen Repository

NCT00896935 | Recruiting DMC

• 5 other identifiers: CDR0000597579P30CA023074UARIZ-06-0609-04UARIZ-BIO#A06035UARIZ-SRC18042
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Conditions

Cancer

Keywords

cancer

Outcome Measures

Primary Outcomes (1)

• Provision of tissue samples and biospecimens for translational study

  An electronic record of the specimens is kept in a secure, web-based database. Follow-up information from patients will be obtained from the patient medical record, and updated every 6 months

  July 2024

Interventions

biologic sample preservation procedure OTHER

biologic sample preservation procedure

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.

DISEASE CHARACTERISTICS: * Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer PATIENT CHARACTERISTICS: * NA PRIOR CONCURRENT THERAPY: * NA As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• University of Arizona: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Arizona Cancer Center at University of Arizona Health Sciences Center

Tucson, Arizona, 85724-5024, United States

RECRUITING

Related Links

• Clinical trial summary from the National Cancer Institute's PDQ® database

Biospecimen

Retention: SAMPLES WITH DNA

Tissue will be collected and preserved from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing.

MeSH Terms

Conditions

Neoplasms

Study Officials

• Setsuko K. Chambers, MD

  University of Arizona

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Arizona Cancer Center at University of Arizona Health Sciences

CONTACT

520-626-0950

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 9, 2009
• First Posted: May 12, 2009
• Study Start: August 1, 2006
• Primary Completion (Estimated): July 1, 2030
• Study Completion (Estimated): July 1, 2030
• Last Updated: September 4, 2025

Record last verified: 2025-08

Locations

US (1)